Augmenting chemotherapy response through EMAP II combination in experimental pancreatic cancer

被引：0
|
作者：
Awasthi, N. [1 ]
Schwarz, M. A. [1 ]
Yen, P. L. [1 ]
Schwarz, R. [1 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.294
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
294
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Combination or single-agent chemotherapy as adjuvant treatment for pancreatic cancer? Opening opinion: combination chemotherapy
    Conroy, Thierry
    Van Laethem, Jean-Luc
    LANCET ONCOLOGY, 2019, 20 (03): : 336 - 337
  • [32] Combination chemotherapy improves survival in patients with resected pancreatic cancer
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2016, 77 (07) : 385 - 385
  • [33] Combination of nimotuzumab, gemcitabine & cisplatin chemotherapy in unresectable pancreatic cancer
    Koner, S.
    Gupta, P.
    Sen, A.
    Sultania, N.
    Mukhopadhyay, S.
    Mukhopadhyay, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 37 - 37
  • [34] Gemcitabine and Oxaliplatin Combination Chemotherapy for Patients with Refractory Pancreatic Cancer
    Isayama, Hiroyuki
    Nakai, Yousuke
    Yamamoto, Keisuke
    Sasaki, Takashi
    Mizuno, Suguru
    Yagioka, Hiroshi
    Yashima, Yoko
    Kawakubo, Kazumichi
    Kogure, Hirofumi
    Arizumi, Toshihiko
    Togawa, Osamu
    Ito, Yukiko
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Sasahira, Naoki
    Hirano, Kenji
    Tsujino, Takeshi
    Tada, Minoru
    Omata, Masao
    Koike, Kazuhiko
    ONCOLOGY, 2011, 80 (1-2) : 97 - 101
  • [35] Combination chemotherapy of pancreatic cancer with gemcitabine and perillyl alcohol.
    Crowell, PL
    Wiseman, DA
    CLINICAL CANCER RESEARCH, 2000, 6 : 4567S - 4567S
  • [36] Enhancing standard chemotherapy response by targeted inhibition of MAPK signaling pathways in experimental pancreatic cancer
    Awasthi, Niranjan
    Monahan, Sheena
    Schwarz, Margaret A.
    Schwarz, Roderich E.
    CANCER RESEARCH, 2016, 76
  • [37] Enhancing pancreatic cancer chemotherapy through photochemical internalisation
    Rosado, Maria
    Mahamed, Ismahan
    Garcia-Sampedro, Andres
    MacRoberts, Sandy
    Selbo, Pal
    Pereira, Stephen
    Acedo, Pilar
    CANCER RESEARCH, 2024, 84 (17)
  • [38] The Role of Akt Activation in the Response to Chemotherapy in Pancreatic Cancer
    Parsons, Colin M.
    Muilenburg, Diego
    Bowles, Tawnya L.
    Virudachalam, Subbulakshmi
    Bold, Richard J.
    ANTICANCER RESEARCH, 2010, 30 (09) : 3279 - 3289
  • [39] A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer
    Oh, Do-Youn
    Cha, Yongjun
    Choi, In-Sil
    Yoon, So-Young
    Choi, In Keun
    Kim, Jee Hyun
    Oh, Sang Cheul
    Kim, Chang Duck
    Kim, Jae Sun
    Bang, Yung-Jue
    Kim, Yeul Hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) : 527 - 536
  • [40] A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer
    Do-Youn Oh
    Yongjun Cha
    In-Sil Choi
    So-Young Yoon
    In Keun Choi
    Jee Hyun Kim
    Sang Cheul Oh
    Chang Duck Kim
    Jae Sun Kim
    Yung-Jue Bang
    Yeul Hong Kim
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 527 - 536
12345